Chandra Dhandapani
Known title: DirectorCIK: 0001750288
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CBRE Faces Broker Departures as Q3 Outlook Looms. Recent reports show several senior brokers have left CBRE for rivals such as Cushman & Wakefield and JLL, including a recent wave of Chicago executives. The departures come as analysts and investors look ahead to CBRE’s third‑quarter results, which have been described as a “winning streak.” At the same time, office vacancy rates in markets like Dallas‑Fort Worth have fallen, suggesting continued demand for commercial space. These developments could influence the company’s brokerage revenue and overall performance.
Transaction History
| NTRS | ▲ Buy | Grant | 31 | $5K | 10/1/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 207 | $35K | 9/30/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 26 | $5K | 7/1/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 201 | $35K | 6/30/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 35 | $6K | 4/21/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 989 | $0 | 4/21/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 20 | $3K | 4/1/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 251 | $35K | 3/31/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 19 | $3K | 1/1/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 256 | $35K | 12/31/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 18 | $2K | 10/1/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 260 | $35K | 9/30/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 16 | $2K | 7/1/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 267 | $34K | 6/30/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 1,902 | $0 | 4/22/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 54 | $5K | 4/22/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 5 | $522 | 4/1/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 287 | $28K | 3/31/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 3 | $319 | 1/1/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 268 | $27K | 12/31/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 1 | $89 | 10/1/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 305 | $27K | 9/30/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 119 | $10K | 6/30/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 1,607 | $0 | 5/29/2024 | View on chart |
| CBRE | ▲ Buy | Grant | 14,841 | $0 | 3/25/2024 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 5,841 | $559K | 3/25/2024 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 2,291 | $216K | 3/10/2024 | View on chart |
| CBRE | ▲ Buy | Grant | 19,862 | $0 | 3/5/2024 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 11,030 | $1.0M | 3/3/2024 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 1,322 | $119K | 2/25/2024 | View on chart |
| CBRE | ▼ Sell | Open Market | 11,925 | $1.1M | 2/16/2024 | View on chart |
| CBRE | ▼ Sell | Gift | 3,185 | $0 | 2/16/2024 | View on chart |
| CBRE | ▲ Buy | Grant | 30,365 | $0 | 1/23/2024 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 10,279 | $888K | 1/23/2024 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 4,556 | $371K | 12/1/2023 | View on chart |
| CBRE | ▼ Sell | Gift | 3,683 | $0 | 8/11/2023 | View on chart |
| CBRE | ▼ Sell | Open Market | 6,551 | $551K | 8/11/2023 | View on chart |
| CBRE | ▼ Sell | Open Market | 301 | $23K | 5/30/2023 | View on chart |
| CBRE | ▼ Sell | Open Market | 6,315 | $476K | 5/30/2023 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 287 | $22K | 5/19/2023 | View on chart |
| CBRE | ▲ Buy | Grant | 23,281 | $0 | 3/10/2023 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 10,482 | $901K | 3/3/2023 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 1,074 | $91K | 2/28/2023 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 843 | $72K | 2/25/2023 | View on chart |
| CBRE | ▲ Buy | Grant | 22,410 | $0 | 2/10/2023 | View on chart |
| CBRE | ▲ Buy | Grant | 2,918 | $0 | 5/19/2022 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 2,211 | $211K | 3/3/2022 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 2,414 | $234K | 2/28/2022 | View on chart |
| CBRE | ▲ Buy | Grant | 13,434 | $0 | 2/25/2022 | View on chart |
| CBRE | ▲ Buy | Grant | 22,518 | $0 | 2/18/2022 | View on chart |
| CBRE | ▼ Sell | Tax Withholding | 662 | $67K | 2/16/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Northern Trust Q3 Earnings Loom Amid Mixed Sector News
Northern Trust is approaching its third-quarter earnings release, with analysts focusing on revenue and EPS estimates. Recent reports indicate the stock has experienced a sharp decline, joining other financial peers in a downturn. While one firm reaffirmed a positive outlook citing the company's quality, the broader sector remains under pressure.
Northern Trust Q3 Earnings Loom Amid Mixed Sector News. Northern Trust is approaching its third-quarter earnings release, with analysts focusing on revenue and EPS estimates. Recent reports indicate the stock has experienced a sharp decline, joining other financial peers in a downturn. While one firm reaffirmed a positive outlook citing the company's quality, the broader sector remains under pressure.